PhD | CardioRenal
Joined August 2016
- Tweets 343
- Following 633
- Followers 462
- Likes 3,209
11 Photos and videos
Massimo Nardone retweeted
Jan 27
RESEARCH ARTICLE: Cardiovascular-Kidney Effects of Dapagliflozin in Patients at Cardiovascular Risk With or Without Type 2 Diabetes: Results of a Randomized, Double-Blind, Placebo-Controlled Trial @massnardone @DSchnekenB
ahajrnls.org/4rhIcAj
7
24
1,451
7 Nov 2025
Amylin and the renin-angiotensin system: risk or opportunity in amylin-based therapy? - The Lancet thelancet.com/journals/lance…
1
66
Massimo Nardone retweeted
Beyond a singular focus on #GLP-1: why we need a new nomenclature now thelancet.com/journals/landi…
multihormone receptor modulator (#MHRM)
1
10
32
2,233
Massimo Nardone retweeted
30 Jun 2025
RESEARCH ARTICLE: Establishing Reference Values for Pulse Wave Velocity in Young People: The Youth Vascular Consortium @RachelClimie @VimarshaHK @ProfRuanKruger @JeanneHersant @rosam_bruno @seanagall @alta_schutte @HanssenHenner @pierreboutouyr1
ahajrnls.org/3TihjgR
15
26
1,795
Massimo Nardone retweeted
29 Jun 2025
Research Article by @AndrLTeixeira3 et al. (@Millar_Lab @DrBurr @massnardone @JorB_L @uofg) Interindividual variability in #renal and #muscle #sympatheticresponses to #mentalstress: contributions to #bloodpressure regulation
ow.ly/21BK50WeP85
1
7
26
2,558
Massimo Nardone retweeted
These hard-working @UofG_HHNS authors are bringing us new #exercise research in this #ArticleinPress, Evidence for potentiation in sympathetic neurovascular transduction following exercise in normotensive adults (Massimo Nardone et al.):
ow.ly/5qY350Wh47T
5
9
333
Presented at #ADASciSessions:
In the REDEFINE 1 phase 3a trial, semaglutide at a dose of 2.4 mg with cagrilintide at a dose of 2.4 mg led to significant body-weight reduction in adults without diabetes and with overweight or obesity. Full trial results: nej.md/444aW7f
@ADA_DiabetesPro
2
39
90
27,667
Massimo Nardone retweeted
11 Jun 2025
Short Report by SE Hilton et al. (@massnardone @julianbommarito @Millar_Lab @uofg) Influence of #sex and #aerobicfitness on #bloodpressure during #maximal #treadmill #exercise in young healthy adults 🏃➡️
ow.ly/QhGU50VX2ef
1
6
19
2,724
Massimo Nardone retweeted
23 May 2025
Happy to share our new paper in @japplphysiol examining muscle sympathetic action potential firing after acute cannabis use pubmed.ncbi.nlm.nih.gov/4038…
1
4
29
985
Massimo Nardone retweeted
9 May 2025
That's a wrap! Thanks to everyone who joined us for our Annual Scientific Day at The Old Mill. Such a wonderful opportunity to network and learn.
2
9
354
Massimo Nardone retweeted
11 Apr 2025
Cardiovascular disease in chronic kidney disease
CVD and CKD has a major impact on the prognosis of patients
inflammation, anaemia, volume overload, and the presence of uraemic toxins : involvement of several pathophysiological mechanisms
academic.oup.com/eurheartj/a…
23
49
2,844
Massimo Nardone retweeted
9 Apr 2025
New research from @TGHRI_UHN suggests #diabetes drugs dapagliflozin & empagliflozin may lower heart disease & kidney failure risk in people with #Type1Diabetes.
Findings highlight the need for trials to confirm benefits ➡️ uhnresearch.ca/news/evaluati… #DiabetesResearch
ALT Flatlay image with a clipboard holding a blood sugar tracker document, blood testing devices, a plastic heart-shaped figure, and a stethoscope.
1
7
333
Massimo Nardone retweeted
5 Mar 2025
Dapagliflozin improves estimated CVD and ESKD risk in T1D participants, emphasizing the need for cardiorenal outcome trials in people living with T1D. bit.ly/CJASN0641
@DrValRac
@FrederikPersson
#ASNCJASN
1
44
95
5,671
Massimo Nardone retweeted
21 Feb 2025
Upcoming drug targets for kidney protective effects in chronic kidney disease
🆓doi.org/10.1093/ndt/gfae216
53
114
6,022
6 Feb 2025
Excited to share our contributions to a special supplement on combination therapy in chronic kidney disease @NDTsocial:
Upcoming drug targets for kidney protective effects in chronic kidney disease academic.oup.com/ndt/article…
9
27
1,725
Massimo Nardone retweeted
5 Feb 2025
Check out our new series of reviews on CKD combination therapy in @NDTsocial academic.oup.com/ndt/issue/4…
1
11
55
2,952
Massimo Nardone retweeted
12 Dec 2024
In HFpEF muscle SNS outflow is elevated during rest and exercise, compared to comorbid controls, and relates inversely to exercise capacity #AHAJournals @markbadrov @FlorasLab @massnardone ahajrnls.org/3OP9ZXU
4
10
1,207
Massimo Nardone retweeted
11 Dec 2024
🧐Selected from our joint @ERAkidney and @escardio Cardio-Kidney Collection:
academic.oup.com/ndt/pages/j…
➡️Proximal versus distal diuretics in congestive heart failure
🔓doi.org/10.1093/ndt/gfae058
18
53
3,342
Massimo Nardone retweeted
11 Oct 2024
♥️ Check out our new joint ERA and ESC Cardio-Kidney Collection♥️
👌This collection of articles from NDT/CKJ & the ESC journals sheds light on the critical importance of addressing the intertwined nature of cardiovascular, kidney & metabolic disorders
academic.oup.com/ndt/pages/j…
1
19
67
4,330
Massimo Nardone retweeted
16 Sep 2024
#PostdocAppreciationWeek 👋Meet Massimo (@massnardone), a Postdoctoral Researcher @UHN’s @TGHRI_UHN. Read about his research and what he thinks about the future of health research! > uhnresearch.ca/news/massimo-…
ALT Smiling male researcher with text quotation overlay.
1
3
13
708